Ensayos clínicos

8.676 ensayos encontrados

Por invitaciónClinicalTrials.gov

EuroSIDA Prospective Observational Cohort Study on Clinical and Virological Outcome of European Patients Infected With HIV

OBSERVATIONALInicio: 1 de ene de 1994ID: NCT02699736

ReclutandoFase 3ClinicalTrials.gov

A Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled Study to Evaluate the Efficacy and Safety of Iptacopan (LNP023) in Idiopathic Immune-complex-mediated Membranoproliferative Glomerulonephritis (IC-MPGN)

INTERVENTIONALInicio: 2 de oct de 2023ID: NCT05755386

ReclutandoFase 3ClinicalTrials.gov

A Phase 3 Multicenter, Randomized, Double-Blind, Placebo Controlled Trial to Evaluate Efficacy and Safety of Mezagitamab (TAK-079) in Study Participants With Primary IgA Nephropathy in Combination With Stable Background Therapy

INTERVENTIONALInicio: 15 de jul de 2025ID: NCT06963827

ReclutandoFase 3ClinicalTrials.gov

Phase 3, Randomized, Open-label, Controlled, Multiple Dose, Efficacy, Safety, Pharmacokinetic, and Pharmacodynamic Study of Etelcalcetide in Pediatric Subjects 28 Days to < 18 Years of Age With Secondary Hyperparathyroidism and Chronic Kidney Disease Receiving Maintenance Hemodialysis

INTERVENTIONALInicio: 29 de abr de 2019ID: NCT03633708

Activo, no reclutaFase 3ClinicalTrials.gov

A Phase III, Randomised, Multicentre, Double-blind Study to Evaluate the Efficacy, Safety, and Tolerability of Zibotentan/Dapagliflozin Compared to Dapagliflozin Alone in Participants With Chronic Kidney Disease and High Proteinuria

INTERVENTIONALInicio: 7 de nov de 2023ID: NCT06087835

ReclutandoFase 2ClinicalTrials.gov

A Phase IIb, Randomised, Multicentre, Double-Blind Study to Evaluate the Effect of Baxdrostat in Combination With Dapagliflozin Compared With Baxdrostat on Albuminuria in Participants With Chronic Kidney Disease and High Blood Pressure.

INTERVENTIONALInicio: 5 de dic de 2025ID: NCT07222917

CompletadoFase 2ClinicalTrials.gov

An Open-label Pharmacokinetic Study in De Novo Renal Transplant Subjects Receiving a Belatacept Based Immunosuppressant Regimen

INTERVENTIONALInicio: 1 de mar de 2008ID: NCT00578448

CompletadoFase 3ClinicalTrials.gov

A Single-Arm Open-Label Study to Assess the Efficacy, Safety, and Tolerability of Once-Monthly Administration of Intravenous and/or Subcutaneous C.E.R.A for the Maintenance of Hemoglobin Levels in Dialysis Patients With Chronic Renal Anemia

INTERVENTIONALInicio: 1 de oct de 2007ID: NCT00517413

TerminadoFase 2ClinicalTrials.gov

A Randomized, Open-label, Two Arm, Parallel Group, Proof-of-concept Clinical Trial to Investigate the Efficacy and Safety of LNP023 Compared With Rituximab in the Treatment of Subjects With Idiopathic Membranous Nephropathy

INTERVENTIONALInicio: 23 de nov de 2019ID: NCT04154787

CompletadoFase 3ClinicalTrials.gov

Extension Study to the Multicenter, Open-label, Randomized, Controlled Study CRAD001H2304 to Evaluate the Long-term Efficacy and Safety of Concentration-controlled Everolimus in Liver Transplant Recipient

INTERVENTIONALInicio: 31 de mar de 2010ID: NCT01150097

ReclutandoFase 3ClinicalTrials.gov

A Phase 2/3 Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of Atumelnant Treatment in Pediatric Participants With Congenital Adrenal Hyperplasia Including a Long-Term Extension

INTERVENTIONALInicio: 22 de ene de 2026ID: NCT07159841

CompletadoFase 3ClinicalTrials.gov

A Phase 3, Randomized, Double-blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of QPI-1002 for Prevention of Delayed Graft Function in Recipients of a Donation After Brain Death Older Donor Kidney Transplant

INTERVENTIONALInicio: 1 de mar de 2016ID: NCT02610296

ReclutandoFase 3ClinicalTrials.gov

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Ravulizumab in Adult Participants With Immunoglobulin A Nephropathy (IgAN)

INTERVENTIONALInicio: 29 de mar de 2024ID: NCT06291376

CompletadoFase 4ClinicalTrials.gov

Hospitalization and Mortality in Iron Deficient, Anemic Patients With Chronic Kidney (CKD) and Heart Failure Receiving Intravenous Iron Therapy: A Five Year Follow-up From a Pilot Study

INTERVENTIONALInicio: 1 de mar de 2006ID: NCT02392910

CompletadoFase 3ClinicalTrials.gov

A Phase 3, Multi-center, Double-blind, Placebo-controlled, Parallel-arm Trial to Determine Long-term Safety and Efficacy of Oral Tolvaptan Tablets Regimens in Adult Subjects With Autosomal Dominant Polycystic Kidney Disease

INTERVENTIONALInicio: 1 de ene de 2007ID: NCT00428948

Activo, no reclutaFase 3ClinicalTrials.gov

A Phase 3, Randomized, Double-blind, Placebo-controlled Study of Atrasentan in Patients With IgA Nephropathy at Risk of Progressive Loss of Renal Function

INTERVENTIONALInicio: 11 de dic de 2020ID: NCT04573478

CompletadoFase 2ClinicalTrials.gov

A 12-week, Phase 2 Open-label, Sequential Dose Cohort Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of CRN04894 Treatment in Participants With Congenital Adrenal Hyperplasia (TouCAHn)

INTERVENTIONALInicio: 3 de jul de 2023ID: NCT05907291

CompletadoFase 3ClinicalTrials.gov

A Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter, Event-driven Phase 3 Study to Investigate the Safety and Efficacy of Finerenone, in Addition to Standard of Care, on the Progression of Kidney Disease in Subjects With Type 2 Diabetes Mellitus and the Clinical Diagnosis of Diabetic Kidney Disease

INTERVENTIONALInicio: 17 de sept de 2015ID: NCT02540993

ReclutandoFase 3ClinicalTrials.gov

A 6-month Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety and PK/PD of an age-and Body Weight-adjusted Oral Finerenone Regimen, in Addition to an ACEI or ARB, for the Treatment of Children, 6 Months to <18 Years of Age, With Chronic Kidney Disease and Proteinuria

INTERVENTIONALInicio: 28 de mar de 2022ID: NCT05196035

ReclutandoClinicalTrials.gov

Medtronic Product Surveillance Registry

OBSERVATIONALInicio: 1 de ene de 2012ID: NCT01524276